Diabetes Remote Patient Monitoring Pilot

Share on Facebook Share on Twitter Share on Linkedin Email this link

This grant opportunity has closed.

Grants of $5,000 (Excl. GST) are available to five successful general practice or Aboriginal Community Controlled Health Services to pilot the use of FreeStyle Flash Glucose Monitoring systems with up to 12 patients with insulin dependent type 2 diabetes mellitus.

The Hunter New England Central Coast Primary Health Network will fund the purchase of the FreeStyle Flash Glucose Monitoring systems and the evaluation of the pilot.

The aim of the project is to improve insulin dependent type 2 diabetes blood glucose control in people with poor glycaemic awareness or suboptimal glycaemic control.

In parallel to the pilot, the PHN will engage a provider to evaluate the pilot. The purpose of the evaluation is to determine the effectiveness, appropriateness, and value of the intervention for the management of patients with insulin dependent type 2 diabetes mellitus in the primary care setting. This evaluation will provide evidence to inform decisions on scalability for further expansion across the PHN region.

Applications for the pilot close May 14, 2021.

Grants of $5,000 (Excl. GST) are available to five successful general practice or Aboriginal Community Controlled Health Services to pilot the use of FreeStyle Flash Glucose Monitoring systems with up to 12 patients with insulin dependent type 2 diabetes mellitus.

The Hunter New England Central Coast Primary Health Network will fund the purchase of the FreeStyle Flash Glucose Monitoring systems and the evaluation of the pilot.

The aim of the project is to improve insulin dependent type 2 diabetes blood glucose control in people with poor glycaemic awareness or suboptimal glycaemic control.

In parallel to the pilot, the PHN will engage a provider to evaluate the pilot. The purpose of the evaluation is to determine the effectiveness, appropriateness, and value of the intervention for the management of patients with insulin dependent type 2 diabetes mellitus in the primary care setting. This evaluation will provide evidence to inform decisions on scalability for further expansion across the PHN region.

Applications for the pilot close May 14, 2021.